Development and validation of a functional ex vivo paclitaxel and eribulin sensitivity assay for breast cancer, the REMIT assay

Related articles

1. Integrated Patient-Derived Xenograft and Patient-Derived Cell Models Reveal Therapeutic Vulnerabilities Beyond Standard-of-Care Therapy in Endometrial Cancer

   This article has 17 authors:

   1. Tianyue Li
   2. Fang Huang
   3. Xiaohao Huang
   4. Ella Pate
   5. Riley Rosenmeyer
   6. Mya Messenger
   7. Kaylee McSweeney
   8. Samuel Robinson
   9. Adam Deters
   10. Lauren Buchanan
   11. Maggie Meehan
   12. Nandini Patel
   13. Allison Diekema
   14. Yiqin Xiong
   15. Xiaofang Zhang
   16. Xiangbing Meng
   17. Shujie Yang

2. Integrated ex vivo screening and transcriptomic profiling to prioritize drug combinations for rare cancers

   This article has 19 authors:

   1. Ritu C. Shah
   2. Alex T. Larsson
   3. Belinda B. Garana
   4. Yang Lyu
   5. Zachary Seeman
   6. Elizabeth Rono
   7. Kyle B. Williams
   8. Dana Borcherding
   9. Kangwen Xiao
   10. Xiaochun Zhang
   11. Yannick Mahlich
   12. Jeremy Jacobson
   13. Lisa B. Fridman
   14. Yan Zhou
   15. Christine A. Pratilas
   16. Angela C. Hirbe
   17. David K. Wood
   18. David A. Largaespada
   19. Sara J.C. Gosline

3. Ex vivo human tumor slices more accurately predict patient responses to an oncolytic virus than in vivo mouse models

   This article has 23 authors:

   1. Jose Maldonado
   2. Thomas Wong
   3. Jia-Shiun Leu
   4. Nourhan Abdelfattah
   5. Han Nhat Tran
   6. David Baskin
   7. Robert Rostomily
   8. Nestor Esnaola
   9. Kristin Huntoon
   10. Betty YS Kim
   11. Wen Jiang
   12. Syed Muddassir
   13. Amanda Anderson
   14. Preeti Marie
   15. Alaa Tamim
   16. Natalie Fowlkes Wall
   17. Taku Yoshida
   18. Masamichi Mori
   19. Serguei Soukharev
   20. Shinsuke Nakao
   21. David Menter
   22. Scott Kopetz
   23. Kyuson Yun